Back to All Clinical Evidence
Evidence Category:
Anti-Microbial Stewardship

Anti-Microbial Stewardship

In 33.3% of patients prescribed systemic antibiotics, no CSS were present. Prescribing patterns did not correlate with bacterial load

Reliance on CSS to diagnose clinically significant bacterial burden in chronic wounds leads to the haphazard use of antimicrobials

Improved methods of identifying bacterial burden and infection (e.g. MolecuLight) are needed to enhance antimicrobial stewardship efforts in wound care 


Fluorescence imaging aids antimicrobial stewardship by supporting evidence-based decision-making at the point of care

Also increased communication, enhanced efficiency, and improved continuity of care between wound care providers and hospital sites


Reliance on CSS to diagnose clinically significant bacterial burden in chronic wounds leads to the haphazard use of antimicrobials

Improved methods of identifying bacterial burden and infection are needed to enhance antimicrobial stewardship efforts in wound care

MolecuLight i:X can provide utility in point-of-care detection of elevated bacterial burden  


Fluorescence imaging was used to meet Joint Commission guidelines for an antimicrobial stewardship program

Combined with clinical examination of signs and symptoms of infection, the MolecuLight imaging procedure improves the clinician’s ability to diagnose infection

Antimicrobial stewardship will soon become part of standard wound center reporting


Fluorescence images provided the clinician with a “map” to inform wound sampling, cleaning, and location of surgical debridement

Heavy bacterial load was confirmed by microbiology methods in all wounds exhibiting red fluorescence

Fluorescence images identified asymptomatic patients and highlighted areas of clinical concern that otherwise would have been overlooked